Intrauterine devices and pelvic inflammatory disease: an international perspective
- 1 March 1992
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 339 (8796) , 785-788
- https://doi.org/10.1016/0140-6736(92)91904-m
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prolonged intrauterine contraception: A seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDSContraception, 1991
- Use of contraception and family planning services in the United States, 1988.American Journal of Public Health, 1990
- Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device useBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- The TCu380A, TCu220C, multiload 250 and nova T IUDs at 3, 5 and 7 years of use — Results from three randomized multicentre trialsContraception, 1990
- Preventing IUCD‐related pelvic infection: the efficacy of prophylactic doxycycline at insertionBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Life‐table methods for contraceptive researchStatistics in Medicine, 1986
- Pelvic infection: a comparison of the Dalkon shield and three other intrauterine devices.BMJ, 1984
- Interval IUD insertion in parous women: A randomized multicentre comparative trial of the lippes Loop D, TCu220C and the Copper 7Contraception, 1982
- Pelvic inflammatory disease and the intrauterine device: findings in a large cohort study.BMJ, 1981
- The intrauterine device: A bacteriologic study of the endometrial cavityAmerican Journal of Obstetrics and Gynecology, 1966